Key Candidate Genes – VSIG2 of Colon Cancer Identified by Weighted Gene Co-Expression Network Analysis

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Sanz-Garcia E, Argiles G, Elez E, et al. BRAF mutant colorectal cancer: prognosis, treatment, and new perspectives. Ann Oncol. 2017;28(11):2648–2657. doi:10.1093/annonc/mdx40129045527
   PubMed Web of Science ®Google Scholar
• Corcoran RB, André T, Atreya CE, et al. Combined BRAF, EGFR, and MEK inhibi-tion in patients with BRAF(V600E)-mutant colorectal cancer. Cancer Discov. 2018;8:428–443. doi:10.1158/2159-8290.CD-17-122629431699
   PubMed Web of Science ®Google Scholar
• Hamzehzadeh L, Khadangi F, Ghayoor Karimiani E, et al. Common KRAS and NRAS gene mutations in sporadic colorectal cancer in Northeastern Iranian patients. Curr Probl Cancer. 2018;42(6):572–581. doi:10.1016/j.currproblcancer.2018.05.00129921458
   PubMed Web of Science ®Google Scholar
• Reggiani Bonetti L, Barresi V, Bettelli S, et al. Analysis of KRAS, NRAS, PIK3CA, and BRAF mutational profile in poorly differentiated clusters of KRAS-mutated colon cancer. Hum Pathol. 2017;62:91–98. doi:10.1016/j.humpath.2016.12.01128025078
   PubMed Web of Science ®Google Scholar
• Saito M, Momma T, Kono K. Targeted therapy according to next generation sequencing-based panel sequencing. Fukushima J Med Sci. 2018;64:9–14. doi:10.5387/fms.2018-0229628467
   PubMed Web of Science ®Google Scholar
• Deshiere A, Berthet N, Lecouturier F, et al. Molecular characterization of equine infectious anemia viruses using targeted sequence enrichment and next generation sequencing. Virology. 2019;537:121–129. doi:10.1016/j.virol.2019.08.01631493650
   PubMed Web of Science ®Google Scholar
• Meng H, Wang L, You H, et al. Circular RNA expression profile of liver tissues in an EtOH‑induced mouse model of alcoholic hepatitis. Eur J Pharmacol. 2019;862:172642. doi:10.1016/j.ejphar.2019.17264231493407
   PubMed Web of Science ®Google Scholar
• Harada K, Okamoto W, Mimaki S, et al. Comparative sequence analysis of patient-matched primary colorectal cancer, metastatic, and recurrent metastatic tumors after adjuvant FOLFOX chemotherapy. BMC Cancer. 2019;19(1):255. doi:10.1186/s12885-019-5479-630898102
   PubMed Web of Science ®Google Scholar
• Hu Y, He C, Liu JP, et al. Analysis of key genes and signaling pathways involved in Helicobacter pylori-associated gastric cancer based on the cancer genome atlas database and RNA sequencing data. Helicobacter. 2018;23:e12530. doi:10.1111/hel.1253030175534
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Fujita M. Whole genome sequencing analysis for cancer genomics and precision medicine. Cancer Sci. 2018;109:513–522. doi:10.1111/cas.1350529345757
   PubMed Web of Science ®Google Scholar
• Jia R, Zhao H, Jia M, et al. Identification of co-expression modules and potential biomarkers of breast cancer by WGCNA. Gene. 2020;750:144757. doi:10.1016/j.gene.2020.14475732387385
   PubMed Web of Science ®Google Scholar
• Li A, Horvath S. Network neighborhood analysis with the multi-node topological overlap measure. Bioinformatics. 2007;23(2):222–231. doi:10.1093/bioinformatics/btl58117110366
   PubMed Web of Science ®Google Scholar
• Yip AM, Horvath S. Gene network interconnectedness and the generalized topological overlap measure. BMC Bioinform. 2007;8:22. doi:10.1186/1471-2105-8-22
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Furumichi M, Tanabe M, et al. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 2017;45(D1):D353–D361. doi:10.1093/nar/gkw109227899662
   PubMed Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25(1):25–29. doi:10.1038/7555610802651
   PubMed Web of Science ®Google Scholar
• Xie P, Mo JL, Liu JH, et al. Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update. Cell Oncol. 2020;43(6):989–1001. doi:10.1007/s13402-020-00529-1
   PubMed Web of Science ®Google Scholar
• Zhang YH, Shi WN, Wu SH, et al. SphK2 confers 5-fluorouracil resistance to colorectal cancer via upregulating H3K56ac-mediated DPD expression. Oncogene. 2020;39(29):5214–5227. doi:10.1038/s41388-020-1352-y32546724
   PubMed Web of Science ®Google Scholar
• Nguyen LH, Ma W, Wang DD, et al. Association between sulfur-metabolizing bacterial communities in stool and risk of distal colorectal cancer in men. Gastroenterology. 2020;158(5):1313–1325. doi:10.1053/j.gastro.2019.12.02931972239
   PubMed Web of Science ®Google Scholar
• Zhang Y, Sun L, Sun Y, et al. Overexpressed CES2 has prognostic value in COAD and knockdown CES2 reverses L-OHP-resistance in COAD cells by inhibition of the PI3K signaling pathway. Exp Cell Res. 2020;389(1):111856. doi:10.1016/j.yexcr.2020.11185631981591
   PubMed Web of Science ®Google Scholar
• Ribelles N, López-Siles J, Sánchez A, et al. A carboxylesterase 2 gene polymorphism as predictor of capecitabine on response and time to progression. Curr Drug Metab. 2008;9(4):336–343. doi:10.2174/13892000878422064618473752
   PubMed Web of Science ®Google Scholar
• Osian G, Procopciuc L, Vlad L, et al. NAT2 polymorphisms and sporadic colorectal cancer survival. J Gastrointestin Liver Dis. 2010;19(4):361–368.21188325
   PubMed Web of Science ®Google Scholar
• Rendo V, Kundu S, Rameika N, et al. Defining eligible patients for allele-selective chemotherapies targeting NAT2 in colorectal cancer. Sci Rep. 2020;10(1):22436. doi:10.1038/s41598-020-80288-z33384440
   PubMed Web of Science ®Google Scholar
• Rendo V, Stoimenov I, Mateus A, et al. Exploiting loss of heterozygosity for allele-selective colorectal cancer chemotherapy. Nat Commun. 2020;11(1):1308. doi:10.1038/s41467-020-15111-432161261
   PubMed Web of Science ®Google Scholar
• Elhodaky M, Diamond AM. Selenium-binding protein 1 in human health and disease. Int J Mol Sci. 2018;19(11):3437. doi:10.3390/ijms19113437
   PubMed Web of Science ®Google Scholar
• Wang N, Chen Y, Yang X, et al. Selenium-binding protein 1 is associated with the degree of colorectal cancer differentiation and is regulated by histone modification. Oncol Rep. 2014;31(6):2506–2514. doi:10.3892/or.2014.314124737289
   PubMed Web of Science ®Google Scholar
• Kim H, Kang HJ, You KT, et al. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival. Proteomics. 2006;6(11):3466–3476. doi:10.1002/pmic.20050062916645984
   PubMed Web of Science ®Google Scholar
• Wang J, Wu G, Manick B, et al. VSIG-3 as a ligand of VISTA inhibits human T-cell function. Immunology. 2019;156(1):74–85. doi:10.1111/imm.1300130220083
   PubMed Web of Science ®Google Scholar
• Huang X, Feng Z, Jiang Y, et al. VSIG4 mediates transcriptional inhibition of Nlrp3 and Il-1β in macrophages. Sci Adv. 2019;5(1):eaau7426. doi:10.1126/sciadv.aau742630662948
   PubMed Web of Science ®Google Scholar
• Li J, Diao B, Guo S, et al. VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism. Nat Commun. 2017;8(1):1322. doi:10.1038/s41467-017-01327-429109438
   PubMed Web of Science ®Google Scholar
• Edin S, Kaprio T, Hagström J, et al. The prognostic importance of CD20+ B lymphocytes in colorectal cancer and the relation to other immune cell subsets. Sci Rep. 2019;9(1):19997. doi:10.1038/s41598-019-56441-831882709
   PubMed Web of Science ®Google Scholar
• Mizuno R, Kawada K, Itatani Y, et al. The role of tumor-associated neutrophils in colorectal cancer. Int J Mol Sci. 2019;20(3):529. doi:10.3390/ijms20030529
   PubMed Web of Science ®Google Scholar
• Locati M, Curtale G, Mantovani A. Diversity, mechanisms, and significance of macrophage plasticity. Annu Rev Pathol. 2020;15(1):123–147. doi:10.1146/annurev-pathmechdis-012418-01271831530089
   PubMed Web of Science ®Google Scholar
• Isidro RA, Appleyard CB. Colonic macrophage polarization in homeostasis, inflammation, and cancer. Am J Physiol Gastrointest Liver Physiol. 2016;311(1):G59–G73. doi:10.1152/ajpgi.00123.201627229123
   PubMed Web of Science ®Google Scholar
• Najafi M, Hashemi Goradel N, Farhood B, et al. Macrophage polarity in cancer: a review. J Cell Biochem. 2019;120(3):2756–2765. doi:10.1002/jcb.2764630270458
   PubMed Web of Science ®Google Scholar
• Jakubzick CV, Randolph GJ, Henson PM. Monocyte differentiation and antigen-presenting functions. Nat Rev Immunol. 2017;17(6):349–362. doi:10.1038/nri.2017.2828436425
   PubMed Web of Science ®Google Scholar
• Sharonov GV, Serebrovskaya EO, Yuzhakova DV, et al. B cells, plasma cells and antibody repertoires in the tumour microenvironment. Nat Rev Immunol. 2020;20(5):294–307. doi:10.1038/s41577-019-0257-x31988391
   PubMed Web of Science ®Google Scholar
• Wang Z, Geng Z, Shao W, et al. Cancer-derived sialylated IgG promotes tumor immune escape by binding to siglecs on effector T cells. Cell Mol Immunol. 2020;17(11):1148–1162. doi:10.1038/s41423-019-0327-931754235
   PubMed Web of Science ®Google Scholar
• Petty AJ, Yang Y. Tumor-associated macrophages: implications in cancer immunotherapy. Immunotherapy. 2017;9(3):289–302. doi:10.2217/imt-2016-013528231720
   PubMed Web of Science ®Google Scholar
• Tanida I, Minematsu-Ikeguchi N, Ueno T, et al. Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy. Autophagy. 2005;1(2):84–91. doi:10.4161/auto.1.2.169716874052
   PubMed Web of Science ®Google Scholar